Bahige B. Chaaban - 02 Apr 2021 Form 4 Insider Report for CEN BIOTECH INC

Reporting relationship: Chief Executive Officer, Director, 10%+ Owner
Issuer ticker: N/A
Reported as of: 02 Apr 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2021, 08:36:56 UTC
Source filing: View source filing
Reporting owner signature: /s/ Bahige Chaaban

Key filing fact

Bahige B. Chaaban filed Form 4 for CEN BIOTECH INC on 03 Jun 2021.

Key facts

This page summarizes Bahige B. Chaaban's Form 4 filing for CEN BIOTECH INC.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2021, 08:36.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CENBF transaction

Common Stock

Award

Transaction value: $0
Shares: +3,106,122
Change %: +39%
Price: $0.000000
Shares after: 11,002,432
Date: 02 Apr 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

3,106,122 shares of common stock of issuer were granted by the issuer on April 2, 2021, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.